Open original FDA record ↗Recall record
- FDA identifier
- Z-2036-2023
- Company in FDA record
- Medtronic Neuromodulation
- FDA classification date
- Jun 29, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A cardioversion procedure may damage the electronics in the Vanta INS device, making the INS unresponsive and non-functional. As of April 19, 2023, Medtronic has received a total of two complaints concerning this issue from patients implanted with a Vanta INS, both of which have resulted in explant procedures.
Source facts
- Action
- Medtronic issued an Urgent Medical Device Correction notice to impacted physicians on 06/06/2023 by letter. The notice explained the problem and the hazard associated with the use of the device during cardioversion procedures. It also provided the following information: Required Actions: " Please communicate to your patients the above Instruction for Prescribers (IFP) and Patient Therapy Guide (PTG) updates regarding programming considerations for cardioversion procedures with patients implanted with Vanta INS devices. " If a patient will be undergoing a cardioversion procedure (e.g., nonemergent scenario) refer to the recommended neurostimulator settings and programming considerations in the Information for Prescribers (IFP) manual which include not turning off your patient s Vanta INS device and reprogramming the settings. " After a cardioversion procedure, confirm that the neurostimulator is functioning and programmed as intended. Contact Medtronic if you have any questions. " For patients who are considering a new or replacement implant, and who have concomitant conditions such that they may require future cardioversion, please talk to these patients about the relative benefits and risks associated with proceeding with a Vanta INS device. " Share this notice with all those who need to be aware of this issue within your organization or to any organization where the potentially affected devices have been transferred and maintain a copy of this notice in your records. " Please complete and return the Customer Confirmation Form enclosed with this letter, acknowledging that you have received this information. Notification will be to the patient level.
- Initiated
- 2023-06-06
- Root cause
- Device Design
- Distribution
- Worldwide distribution.
- Recall number
- Z-2036-2023
- Recall status
- Open, Classified
- CDRH record ID
- 200873
- FDA classified
- 2023-06-29
- Recall event number
- 92413